Prologue: Evidence Informing the GRAPPA 2021 Treatment Recommendations, by Domain

REFERENCES

1. 1.↵
   1. Taylor W,
   2. Gladman D,
   3. Helliwell P, et al.

   Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54:2665-73.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Kavanaugh AF,
   2. Ritchlin CT; GRAPPA Treatment Guideline Committee

   . Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines. J Rheumatol 2006;33:1417-21.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Mallbris L,
   2. Ritchlin CT,
   3. Ståhle M.

   Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep 2006;8:355-63.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Peters MJ,
   2. van der Horst-Bruinsma IE,
   3. Dijkmans BA,
   4. Nurmohamed MT.

   Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004;34:585-92.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Ritchlin CT,
   2. Kavanaugh A,
   3. Gladmann DD, et al.

   Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 2009;68:1387-94.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Coates LC,
   2. Kavanaugh A,
   3. Mease PJ, et al.

   Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol 2016;68:1060-71.

   OpenUrl
7. 7.↵
   1. Coates LC,
   2. Soriano ER,
   3. Corp N, et al; GRAPPA Treatment Recommendations domain subcommittees

   . Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nat Rev Rheumatol 2022;18:465-79.

   OpenUrlPubMed
8. 8.↵
   1. Gossec L,
   2. Baraliakos X,
   3. Kerschbaumer A, et al.

   EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis 2020;79:700-12.

   OpenUrlAbstract/FREE Full Text
9. 9.
   1. Singh JA,
   2. Guyatt G,
   3. Ogdie A, et al.

   Special article: 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Arthritis Care Res 2019; 71:2-29.

   OpenUrlPubMed
10. 10.↵
    1. Tillett W,
    2. Allen A,
    3. Tucker L, et al.

    Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope. Rheumatology 2021;60:1588-92.

    OpenUrl
11. 11.↵
    1. Leung YY,
    2. Korotaeva T,
    3. Candia L, et al.

    Management of peripheral arthritis in patients with psoriatic arthritis: an updated literature review informing the 2021 GRAPPA treatment recommendations. J Rheumatol 2023;50:119-30.

    OpenUrlAbstract/FREE Full Text
12. 12.
    1. Callis Duffin K,
    2. Mazzuoccolo LD,
    3. Cura MJ, et al.

    Treatment of psoriasis in patients with psoriatic arthritis: an updated literature review informing the 2021 GRAPPA treatment recommendations. J Rheumatol 2023;50:131-43.

    OpenUrlAbstract/FREE Full Text
13. 13.
    1. Eder L,
    2. Mathew AJ,
    3. Carron P, et al.

    Management of enthesitis in patients with psoriatic arthritis: an updated literature review informing the 2021 GRAPPA treatment recommendations. J Rheumatol 2022 Nov 1 (Epub ahead of print).
14. 14.
    1. Palominos P,
    2. Fernández-Ávila DG,
    3. Coates LC, et al.

    Management of dactylitis in patients with psoriatic arthritis: an updated literature review informing the 2021 GRAPPA treatment recommendations. J Rheumatol 2022 Nov 1 (Epub ahead of print).
15. 15.
    1. Lubrano E,
    2. Chan J,
    3. Queiro-Silva R.

    Management of axial disease in patients with psoriatic arthritis: an updated literature review informing the 2021 GRAPPA treatment recommendations. J Rheumatol 2022 Nov 1 (Epub ahead of print).
16. 16.
    1. Campanholo CB,
    2. Maharaj AB,
    3. Corp N, et al.

    Management of psoriatic arthritis in patients with comorbidities: an updated literature review informing the 2021 GRAPPA treatment recommendations. J Rheumatol 2022 Nov 1 (Epub ahead of print).
17. 17.
    1. Laheru D,
    2. Antony A,
    3. Carneiro S, et al.

    Management of psoriatic arthritis in patients with comorbidities: an updated literature review informing the 2021 GRAPPA treatmentrecommendations. J Rheumatol 2022 Nov 1 (Epub ahead of print).
18. 18.↵
    1. Jadon DR,
    2. Corp N,
    3. van der Windt DA, et al.

    Management of concomitant inflammatory bowel disease or uveitis in patients with psoriatic arthritis: an updated review informing the 2021 GRAPPA treatment recommendations. J Rheumatol 2022 Dec 1 (Epub ahead of print).